Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,227 | 989 | 97.5% |
| Education | $383.76 | 13 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,831 | 204 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,178 | 147 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,378 | 69 | $0 (2024) |
| Lilly USA, LLC | $1,054 | 74 | $0 (2024) |
| PFIZER INC. | $723.98 | 46 | $0 (2024) |
| Astellas Pharma US Inc | $720.08 | 37 | $0 (2024) |
| Amgen Inc. | $625.26 | 37 | $0 (2024) |
| ABBVIE INC. | $623.41 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $595.74 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $533.83 | 37 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,096 | 108 | AstraZeneca Pharmaceuticals LP ($602.34) |
| 2023 | $1,714 | 106 | GlaxoSmithKline, LLC. ($211.56) |
| 2022 | $1,411 | 96 | Novo Nordisk Inc ($311.61) |
| 2021 | $1,731 | 100 | Astellas Pharma US Inc ($269.63) |
| 2020 | $1,684 | 114 | Novo Nordisk Inc ($466.46) |
| 2019 | $1,676 | 112 | GlaxoSmithKline, LLC. ($405.71) |
| 2018 | $2,646 | 180 | Novo Nordisk Inc ($684.67) |
| 2017 | $2,653 | 186 | Novo Nordisk Inc ($421.64) |
All Payment Transactions
1,002 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Biological | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: VACCINE | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: ANTIBIOTIC | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 852 | 1,542 | $436,224 | $109,455 |
| 2022 | 12 | 1,064 | 1,781 | $485,630 | $132,825 |
| 2021 | 10 | 1,032 | 1,749 | $467,587 | $127,147 |
| 2020 | 13 | 882 | 1,430 | $240,091 | $82,182 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 869 | $308,255 | $66,879 | 21.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 53 | 53 | $26,341 | $14,969 | 56.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 91 | 95 | $13,110 | $7,152 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 128 | $32,768 | $6,610 | 20.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 103 | $22,976 | $4,532 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 99 | $5,544 | $2,970 | 53.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 50 | $7,428 | $1,733 | 23.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 53 | 53 | $2,968 | $1,590 | 53.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $5,532 | $1,439 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $7,154 | $928.89 | 13.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 14 | $2,002 | $511.23 | 25.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 38 | $494.00 | $82.07 | 16.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 14 | 14 | $1,652 | $58.37 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 368 | 951 | $337,245 | $76,432 | 22.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 67 | 67 | $28,140 | $18,660 | 66.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 292 | $74,560 | $17,577 | 23.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 121 | 124 | $12,028 | $8,661 | 72.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 128 | 131 | $7,336 | $3,743 | 51.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 92 | 92 | $5,152 | $2,637 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $9,709 | $2,440 | 25.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $3,456 | $2,128 | 61.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 12 | 12 | $4,308 | $328.55 | 7.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 36 | 38 | $760.00 | $84.52 | 11.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 22 | 22 | $2,596 | $74.83 | 2.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 17 | $340.00 | $58.16 | 17.1% |
About Dr. Clinton Sharp, M.D
Dr. Clinton Sharp, M.D is a Family Medicine healthcare provider based in Slidell, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508855198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clinton Sharp, M.D has received a total of $15,611 in payments from pharmaceutical and medical device companies, with $2,096 received in 2024. These payments were reported across 1,002 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($15,227).
As a Medicare-enrolled provider, Sharp has provided services to 3,830 Medicare beneficiaries, totaling 6,502 services with total Medicare billing of $451,609. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Slidell, LA
- Active Since 10/17/2005
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508855198
Products in Payments
- Ozempic (Drug) $1,180
- TRELEGY ELLIPTA (Drug) $1,095
- Victoza (Drug) $833.90
- TRULICITY (Drug) $511.32
- ANORO (Drug) $494.14
- BREZTRI (Drug) $444.69
- NURTEC ODT (Drug) $412.81
- XIFAXAN (Drug) $372.94
- Aimovig (Biological) $344.17
- MYRBETRIQ (Drug) $341.04
- VRAYLAR (Drug) $340.10
- Rybelsus (Drug) $331.78
- FARXIGA (Drug) $322.27
- SYMBICORT (Drug) $295.65
- JARDIANCE (Drug) $256.65
- ENTRESTO (Drug) $253.97
- JANUVIA (Drug) $248.55
- Vascepa (Drug) $240.21
- TOUJEO (Drug) $234.12
- UBRELVY (Drug) $208.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Slidell
Dr. Michael Casey, M.d, M.D
Family Medicine — Payments: $14,641
Dr. Miyoshi Henry, M.d, M.D
Family Medicine — Payments: $13,718
Chequita Williams, Md, MD
Family Medicine — Payments: $13,154
Rory Duffour, M.d, M.D
Family Medicine — Payments: $10,860
Dr. Ryan Arnold, M.d, M.D
Family Medicine — Payments: $7,168
Dr. Hatem Hamed, M.d.,M.b.,Ch.b.,M.s, M.D.,M.B.,CH.B.,M.S
Family Medicine — Payments: $3,332